FDA issues emergency use authorization for Johnson & Johnson vaccine

Good Morning America – February 28, 2021 Medical experts on Friday unanimously recommended that drug regulators clear Johnson & Johnson’s COVID-19 vaccine for Emergency Use Authorization (EUA); Saturday, EUA was granted. The vaccine was developed in a collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).

Additional coverage:

MSNBC – FDA expected to approve J&J vaccine for emergency use

MSNBC – The first Johnson & Johnson vaccines have been shipped. What is next? (Note: interview begins around 2:35)

Boston Globe – FDA advisory panel recommends Johnson & Johnson COVID-19 vaccine be cleared for use. Authorization is likely this weekend

WCVB Channel 5 – Researchers at Boston hospital played key role in Johnson & Johnson vaccine development

Boston Business Journal – Five things you need to know today, and a few follow-ups for you

CBS Boston – Advisers endorse single-shot COVID-19 vaccine from Johnson & Johnson MIT Technology Review – The one-shot vaccine from Johnson & Johnson now has FDA support in the US